Aurobindo Pharma CNS portfolio expands with perampanel, adding to recent epilepsy approvals as its USFDA ANDA count reaches 599.
UP hospital bills face scrutiny as medicine price gaps widen inside treatment packages, raising questions over mark-ups, discounts and patient costs.
Severe headache, fever, confusion, and neck stiffness can signal meningitis. On World Meningitis Day 2026, experts explain warning signs and when urgent medical care is needed.
Lixudebart is CSL and Alentis USD 1.6 billion bet on claudin-1, spanning rare kidney diseases and the unmet treatment need in PSC.
Cancer care is entering a new phase as blood-based detection and drug combinations create new paths for earlier diagnosis and stronger treatment.
India dengue vaccine efforts gain relevance as Bangladesh sees its deadliest dengue month of 2026 and Indian cities report rising post-monsoon cases. Qdenga adds a new preventive tool as transmission patterns become less predictable.
The government extends import price curbs on two pharma raw materials, offering domestic producers temporary relief from low-priced Chinese supplies.
Engineered LC3 could make autophagy more programmable, giving researchers greater control over the cell-cleansing pathway. The CSIR-IGIB-led study explores its potential as a therapeutic platform for cancer and neurodegenerative diseases.
India powers primary care through 1.86 lakh Ayushman Arogya Mandirs, delivering 420 million screenings and expanding preventive healthcare nationwide.
Long-acting immunology antibodies are central to Sanofi and Regeneron's expanded alliance, with USD 1 billion upfront and up to USD 7 billion in milestones as they build beyond Dupixent.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
